Histiocytic disorders of children and adults: Introduction to the problem, overview, historical perspective and epidemiology

Histiocytic Disorders of Children and Adults

Volumn , Issue , 2005, Pages 01-13

  Weitzman, Sheila ^a   Egeler, R Maarten ^b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b LEIDEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33745771288     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511545252.002     Document Type: Chapter

References (58)

1. Ambruso, D.R., Hays, T., Zwartjes, W.J., et al. (1980). Successful treatment of lymphohistiocytic reticulosis with phagocytosis with epipodophyllotoxin VP-16-213. Cancer,45, 2516-2520.
2. Arico, M., Haupt, R. and Russotto, V.S., et al. (2001). Langerhans cell histiocytosis in two generations: a new family and review of the literature. Med Pediatr Oncol,36, 314-316.
3. Arico, M., Girschikofsky, M., Genereau, T., et al. (2003). Langerhans cell histiocytosis in adults report from the International Registry of the Histiocyte Society. Eur J Cancer,39, 2341-2348.
4. Bernstrand, C., Cederlund, K., Ahstrom, L., et al. (2000). Smoking preceded pulmonary involvement in adults with Langerhans cell histiocytosis diagnosed in childhood. Acta Paediatr,89, 1389-1392.
5. Bernstrand, C., Carstensen, H., Jakobsen, B., et al. (2003). Immunogenetic heterogeneity in singlesystem and multisystem Langerhans cell histiocytosis. Pediatr Res,54, 30-36.
6. Berry, D.H. and Becton, D.L. (1984). Natural history of histiocytosis X. Hematol Oncol Clin North Am,1, 23-24.
7. Bhatia, S., Nesbit, M.E., Egeler, R.M., et al. (1997). Epidemiologic study of Langerhans cell histiocytosis in children. J Pediatr,130, 774-784.
8. Birbeck, M.S., Breathnach, A.S. and Everall, J.D. (1961). An electron microscopy study of basal melanocytes and high-level clear cells (Langerhans cells) in vitiligo. J Invest Dermatol,37, 51-63.
9. Carstensen, H. and Ornvold, K. (1993). The epidemiology of Langerhans cell histiocytosis in children in Denmark, 1975-89. Med Pediatr Oncol,21, 387-388.
10. Christian, H. (1920). Defects in membraneous bones, exophthalmos and diabetes insipidus: an unusual syndrome of dyspituitarism. Med Clin North Am,3, 849-871.
11. Chu, T., D’Angio, G.J., Favara, B., et al. (1987). Histocytosis syndromes in children. Lancet,1, 208-209.
12. Coppes-Zantinga, A. and Egeler, R.M. (2002). The Langerhans cell histiocytosis X files revealed. Historical review. Br J Haematol,116, 3-9.
13. Donadieu, J. and Pritchard, J. (1999). Langerhans cell histiocytosis - 400bc? Med Pediatr Oncol, 33, 520.
14. Dufourcq-Lagelouse, R., Jabado, N., Le Deist, F., et al. (1999). Linkage of familial hemophagocytic lymphohistiocytosis to 10q21-22 and evidence for heterogeneity. Am J Hum Genet,64, 172-179.
15. Egeler, R.M. and D’Angio, G.J. (1998). Langerhans cell histiocytosis, Preface. Hematol Oncol Clin North Am,12, XV-XVii.
16. Egeler, R.M., Favara, B.E., van Meurs, M., et al. (1999). Differential in situ cytokine profiles of Langerhans-like cells and T cells in Langerhans cell histiocytosis: abundant expression of cytokines relevant to disease and treatment. Blood,94, 4195-4201.
17. Farber, S. (1941). The nature of‘solitary or eosinophilic granuloma’ of bone. Am J Pathol,17, 625-629.
18. Farquhar, J. and Claireaux, A. (1952). Familial haemophagocytic reticulosis. Arch Dis Child,27, 519-525.
19. Favara, B.E., Feller, A.C., Pauli, M., et al. (1997). Contemporary classification of histiocytic disorders. Reclassification Working Group of the Histiocyte Society. Med Pediatr Oncol,29, 157-166.
20. Filipovich, A.H. (1997). Hemophagocytic lymphohistiocytosis: a lethal disorder of immune regulation. J Pediatr,130, 337-338.
21. Fischer, A., Cerf-Bensussan, N., Blanche, S., et al. (1986). Allogeneic bone marrow transplantation for erythrophagocytic lymphohistiocytosis. J Pediatr,108, 267-270.
22. Fisman, D.N. (2000). Hemophagocytic syndromes and infection. EmergInfect Dis,6, 601-608.
23. Glotzbecker, M.P., Carpentieri, D.F. and Dormans, J.P. (2002). Langerhans cell histiocytosis: clinical presentation, pathogenesis, and treatment from the LCH etiology research group at the Children’s Hospital of Philadelphia. UPOJ,15, 67-73.
24. Goransdotter Ericson, K.G., Fadeel, B., Nilsson-Ardnor, S., et al. (2001). Spectrum ofperforin gene mutations in familial hemophagocytic lymphohistiocytosis. Am J Hum Genet,68, 590-597.
25. Hand, A. (1893). Polyuria and tuberculosis. Arch Pediatr,10, 673-675.
26. Henter, J.-I., Elinder, G., Soder, O., et al. (1991a). Incidence in Sweden and clinical features of familial hemophagocytic lymphohistiocytosis. Acta Paediatr Scand,80, 428-435.
27. Henter, J.-I., Elinder, G., Soder, O., et al. (1991b). Hypercytokinemia in familial hemophagocytic lymphohistiocytosis, Blood,78, 2918-2922.
28. Henter, J.-I., Andersson, B., Elinder, G., et al. (1996). Elevated circulating levels of interleukin-1 receptor antagonists but not IL-1 agonists in hemophagocytic lymphohistiocytosis. Med Pediatr Oncol,27, 21-25.
29. Henter, J.-I., Arico, M., Elinder, G., et al. (1998). Familial hemophagocytic lymphohistiocytosis. Hematol Oncol Clin North Am,12, 417-433.
30. Henter, J.-I., Samuelsson-Horne, A., Arico, M., et al. (2002). Treatment of hemophagocytic lym- phohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantatation. Blood,100, 2367-2373.
31. Huang, F. and Arceci, R. (1999). The histiocytoses of infancy. Semin Perinatol,23, 319-331.
32. Imashuku, S. (2000). Advances in the management of hemophagocytic lymphohistiocytosis. Int J Hematol,72, 1-11.
33. Imashuku, S., Ikushima, S., Esumi, N., et al. (1991). Serum levels of interferon-gamma, cytotoxic factor and soluble interleukin-2 receptor in childhood hemophagocytic syndromes. Leukemia lymphoma,3, 287-292.
34. Ishii, E., Ohga, S., Tanimura, M., et al. (1998). Clinical and epidemiologic studies of familial hemophagocytic lymphohistiocytosis in Japan. Japan LCH Study Group. Med Pediatr Oncol, 30, 276-283.
35. Janke, G.E. (1983). Familial hemophagocytic lymphohistiocytosis. Eur J Pediatr,140, 230.
36. Janke, G., Imashuku, S., Elinder, G., et al. (1998). Infection- and malignancy-associated hemo- phagocytic syndromes: secondary hemophagocytic lymphohistiocytosis. Hematol Oncol Clin North Am,12, 435-444.
37. Karis, J., Bernstrand, C., Fadeel, B., et al. (2003). The incidence of Langerhans cell histiocytosis in children in Stockholm County, Sweden 1992-2001. Proceedings of the XIX Meeting of Histiocyte Society, Philadelphia, p. 21.
38. Laman, J.D., Leenen, P.J., Annels, N.E., et al. (2003). Langerhans-cell histiocytosis ‘insight into DC biology’. Trend Immunol, 24, 190-196.
39. Lampert, F. (1998). Langerhans cell histiocytosis. Historical perspectives. Hematol Oncol Clin North Am,12, 213-219.
40. Letterer, E. (1924). Aleukamische retikulose (ein Beitrag zu den proliferativen Erkrankungen des reticuloendothelialapparates). Frankfurter Zeitschritte Pathol,30, 377-394.
41. Lichtenstein, L. (1953). Histiocytosis X: integration of eosinophilic granuloma of bone, Letterer-Siwe disease and Schuller-Christian disease as related manifestations of a single nosologic entity. AMA Arch Pathol,56, 84-102.
42. Lichtenstein, L. and Jaffe, H. (1940). Eosinophilic granuloma of bone. Am J Pathol,16, 595-604.
43. McClain, K., Jin, H., Gresik, V., et al. (1994). Langerhans cell histiocytosis: lack of a viral etiology. Am J Hematol,47, 16-20.
44. McClain, K.L., Laud, P., Wu, W-S., et al. (2003). Langerhans cell histiocytosis patients have HLA CW7 and DR4 types associated with specific clinical presentations and no increased frequency in polymorphisms of the tumor necrosis factor alpha promoter. Med Pediatr Oncol,41, 502-507.
45. Nezelof, C. (1992). The histiocytoses of childhood. Histopathology,21, 395-396.
46. Ohadi, M., Lalloz, M.R.A. and Sham, P. (1999). Localization of a gene for familial hemophago- cytic lymphohistiocytosis at chromosome 9q21.3-22 by homozygosity mapping. Am J Hum Genet,64, 165-171.
47. Osugi, Y., Hara, J., Tagawa, S., et al. (1997). Cytokine production regulating Th-1 and Th-2 cytokines in hemophagocytic lymphohistiocytosis. Blood,89, 4100-4103.
48. Otani, S. and Ehrlich, J. (1940). Soliary granuloma of bone, simulating primary neoplasm. Am J Pathol,16, 479-490.
49. Risdall, R.J., McKenna, R.W., Nesbit, M.E., et al. (1979). Virus-associated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis. Cancer, 44, 993-1002.
50. Risdall, R.J., Dehner, L.P., Duray, P., et al. (1983). Histiocytosis X (Langerhans cell histiocytosis). Prognostic role of histopathology. Arch Pathol Lab Med,107, 59-63.
51. Schuller, A. (1915). Uber eigenartige schadeldefekte im jugendalter. Fortschritte Aufder Gebiete Rontgenstrahlen,23, 12-18.
52. Scott, R. and Robb-Smith, A. (1939). Histiocytic medullary reticulosis. Lancet,2, 194-198.
53. Siwe, S. (1933). Die Reticuloendotheliose-ein neues krankheitsbild unter den hepatospleno- megalien. Zeitschrift fur Kinderheilkunde,55, 212-247.
54. Stepp, S.E., Dufourq-Lagelouse, R., Le Deist, F., et al. (1999). Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science,286, 1957-1959.
55. Stuurman, K.E., Lau, L., Doda, W., et al. (2003). Evaluation of the natural history and long term complications of patients with Langerhans cell histiocytosis of bone. Proc XIX meeting Histiocyte Society, Philadelphia.
56. Takahashi, N., Chubachi, A., Kume, M., et al. (2001). A clinical analysis of 52 adult patients with hemophagocytic syndrome: the prognostic significance of the underlying disease. Int J Hematol,74, 209-213.
57. The French LCH Study Group (1996). A multicentre retrospective survey of LCH: 348 cases observed between 1983 and 1993. Arch Dis Child,75, 17-24.
58. Young, J.W. (1999). Cell fate development in the myeloid system. In: Lotze, M.T. and Thomson, A.W. eds., Dendritic Cells, Academic Press, San Diego, Calfornia, pp. 29-49.